Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yonghao Yang

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Journal of Leukocyte Biology|March 14, 2025
Utility of the neutrophil-to-lymphocyte ratio and the ratio of neutrophil-to-lymphocyte ratio after and before adverse events for differential diagnosis of immune-related adverse events and bacterial infections in cancer patients treated with PD-(L)1 inhibitorsLu Han, Beibei Huang, Linlin Li, et al.
Frontiers in Oncology|September 22, 2023
Argon-helium knife cryoablation plus programmed cell death protein 1 inhibitor in the treatment of advanced soft tissue sarcomas: there is no evidence of the synergistic effects of this combination therapyJiaqiang Wang, Dengwei Zong, Shuping Dong, et al.
Journal of Healthcare Engineering|February 7, 2022
ResNet-BiLSTM: A Multiscale Deep Learning Model for Heartbeat Detection Using Ballistocardiogram SignalsYijun Liu, Yifan Lyu, Zhibin He, et al.
Immunotherapy|October 24, 2018
Combination of PD-1 blockade and RetroNectin<sup>®</sup>-activated cytokine-induced killer in preheavily treated non-small-cell lung cancer: a retrospective studyLingdi Zhao, Lu Han, Yong Zhang, et al.
Molecular and Cellular Biochemistry|April 17, 2023
Indole-3-carboxaldehyde ameliorates ionizing radiation-induced hematopoietic injury by enhancing hematopoietic stem and progenitor cell quiescenceDongwei Guan, Yonghao Yang, Mao Pang, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|April 1, 2026
Multifaceted regulation of immune cells in radiation-induced pulmonary fibrosis: from mechanistic insights to targeted therapiesLi Shen, Wanrong Zhang, Yonghao Yang, et al.
BMC Cancer|November 24, 2020
High cumulative doxorubicin dose for advanced soft tissue sarcomaZhichao Tian, Yang Yang, Yonghao Yang, et al.
Frontiers in Pharmacology|February 16, 2024
Combining nanoparticle albumin-bound paclitaxel with camrelizumab in advanced soft tissue sarcoma: activity, safety, and future perspectivesZhichao Tian, Yushen Feng, Yang Yang, et al.
Immunotherapy|December 15, 2018
Clinical value of neutrophil-to-lymphocyte ratio as a predictor of prognosis of RetroNectin<sup>®</sup>-activated cytokine-induced killer cell therapy in advanced non-small-cell lung cancerLingdi Zhao, Tiepeng Li, Yonghao Yang, et al.
Oncotargets and Therapy|October 3, 2018
Efficacy and safety of trastuzumab as maintenance or palliative therapy in advanced HER2-positive gastric cancerXiaomin Fu, Yong Zhang, Jing Yang, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Journal of Leukocyte Biology|March 14, 2025
Utility of the neutrophil-to-lymphocyte ratio and the ratio of neutrophil-to-lymphocyte ratio after and before adverse events for differential diagnosis of immune-related adverse events and bacterial infections in cancer patients treated with PD-(L)1 inhibitorsLu Han, Beibei Huang, Linlin Li, et al.
Frontiers in Oncology|September 22, 2023
Argon-helium knife cryoablation plus programmed cell death protein 1 inhibitor in the treatment of advanced soft tissue sarcomas: there is no evidence of the synergistic effects of this combination therapyJiaqiang Wang, Dengwei Zong, Shuping Dong, et al.
Journal of Healthcare Engineering|February 7, 2022
ResNet-BiLSTM: A Multiscale Deep Learning Model for Heartbeat Detection Using Ballistocardiogram SignalsYijun Liu, Yifan Lyu, Zhibin He, et al.
Immunotherapy|October 24, 2018
Combination of PD-1 blockade and RetroNectin<sup>®</sup>-activated cytokine-induced killer in preheavily treated non-small-cell lung cancer: a retrospective studyLingdi Zhao, Lu Han, Yong Zhang, et al.
Molecular and Cellular Biochemistry|April 17, 2023
Indole-3-carboxaldehyde ameliorates ionizing radiation-induced hematopoietic injury by enhancing hematopoietic stem and progenitor cell quiescenceDongwei Guan, Yonghao Yang, Mao Pang, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|April 1, 2026
Multifaceted regulation of immune cells in radiation-induced pulmonary fibrosis: from mechanistic insights to targeted therapiesLi Shen, Wanrong Zhang, Yonghao Yang, et al.
BMC Cancer|November 24, 2020
High cumulative doxorubicin dose for advanced soft tissue sarcomaZhichao Tian, Yang Yang, Yonghao Yang, et al.
Frontiers in Pharmacology|February 16, 2024
Combining nanoparticle albumin-bound paclitaxel with camrelizumab in advanced soft tissue sarcoma: activity, safety, and future perspectivesZhichao Tian, Yushen Feng, Yang Yang, et al.
Immunotherapy|December 15, 2018
Clinical value of neutrophil-to-lymphocyte ratio as a predictor of prognosis of RetroNectin<sup>®</sup>-activated cytokine-induced killer cell therapy in advanced non-small-cell lung cancerLingdi Zhao, Tiepeng Li, Yonghao Yang, et al.
Oncotargets and Therapy|October 3, 2018
Efficacy and safety of trastuzumab as maintenance or palliative therapy in advanced HER2-positive gastric cancerXiaomin Fu, Yong Zhang, Jing Yang, et al.
Pageof 5